Blog
Log In
Contact us

Author: Jona Kerma

Categories
News

Sensyne Health and OMNY Health Sign Teaming Agreement to Support Breakthrough Research Through the Power of Real World Data and AI

Sensyne and OMNY will collaborate to develop new proposals to life sciences companies and healthcare providers to use real world data and advanced analytical tools to improve patient outcomes and accelerate the development of new medicines

The Teaming Agreement allows OMNY to engage Sensyne’s data analytics tools and consulting services and provides Sensyne with the potential to access OMNY Health’s 22 million de-identified patient records

Dover, DE and Atlanta, GA. Oxford, U.K. October 13, 2021: Sensyne Health plc (LSE: SENS) (“Sensyne”), the ethical Clinical AI company, and OMNY Health (“OMNY”), a leading US-based real world data company, today announced a strategic teaming relationship.

The arrangement establishes a nimble framework under which Sensyne can subscribe to data offerings via the OMNY Health Platform, which features more than 22 million de-identified patient records across broad therapeutic areas in support of Sensyne’s data analytics work for life science companies. In addition, Sensyne and OMNY have agreed to work together on commercial projects for life science clients to advance and accelerate ethical medical research.  By bringing biopharma clients a joint offering with OMNY real-world data and Sensyne machine learning expertise, both companies—and their health system partners—will have more opportunities to support important life sciences research.

The OMNY data network complements Sensyne’s existing global medical research dataset of 22.1 million patients, ethically sourced through strategic partnerships with US health systems and the UK’s National Health Service (NHS) trusts. With representation from  over 50,000 providers across 40 states, the OMNY Health Platform also offers control, security, and data governance to maximize the utility of information while maintaining compliance with US regulations.  Sensyne will now have a new avenue to access data from OMNY’s catalog of over 22 million unique patient records, significantly enhancing the scale of real world data on which Sensyne can apply its advanced machine learning and bringing the possible combined total of de-identified patient data available for collaborative research to over 44m patients.  

Derek Baird, President, North America, Sensyne Health said:

“This relationship has been forged on a mutual belief in the power of real-world data to support breakthrough insights and discoveries. The team at OMNY, like us, appreciate the complexity of working with longitudinal clinical records, and the trust that health systems place in our companies to analyse de-identified patient data in an ethical, secure, and responsible way.  We share common philosophies and missions, and complementary approaches in responsibly using real-world data to accelerate life science research for clients. This is an exciting alliance, and we are thrilled to be working together.”

Mitesh Rao, MD, CEO, OMNY Health said:

“OMNY Health embraces the opportunity to work with Sensyne Health’s world-class machine learning team and data science professionals, and is thrilled for Sensyne to join the platform.  We aim to revolutionize the healthcare ecosystem through our equality-driven data network while unlocking transformative real world data partnerships across the life sciences industry. This collaboration with Sensyne Health creates even greater possibilities to apply emerging technologies to the unparalleled data we’ve assembled, enabling both companies to ethically innovate on behalf of our respective partners, and most importantly, to create better outcomes for patients.”
Sensyne is working with life science partners on different types of research projects across multiple disease areas. The actionable insights from OMNY’s longitudinal patient data sets will help them with synthetic control arms, patient stratification, patient identification and selection, plus important late-phase clinical trial design, commercialisation, and health economic pricing decisions.

For more information email: lifesciences@omnyhealth.com.

Categories
News

OMNY Health Launches Massive Integrated Dermatology Data Repository and Research Network to Advance Life-Changing Innovations for Patients Suffering from Skin-Related Conditions

ATLANTA, June 23, 2021 /PRNewswire/ — OMNY Health (OMNY Inc.) is pleased to announce it has partnered with the nation’s leading community-based dermatology practices to create a first-of-a-kind integrated, normalized, de-identified electronic health record (EHR) data repository for dermatological research.

The assembled longitudinal data represents care delivered over the past five years by over 1,000 dermatologic providers in more than 30 states, across more than 7.5 million unique patients. OMNY Health works with providers to integrate and standardize their siloed disparate EHR data, enabling the delivery of de-identified data into research-ready subscriptions for Life Sciences organizations, while also delivering insights based on the normalized data back to the data contributors.

At the core of the OMNY Health platform is de-identified, normalized EHR data, further enhanced with tokens that support linkages to data derived from administrative claims, registries and other data resources, while maintaining patient anonymity. OMNY Health leverages natural language processing (NLP) technology to analyze unstructured data to derive insights often buried in clinician notes, such as adverse drug events, social determinants of health, and reasons for therapy changes.

“We are excited to partner with these forward-thinking dermatology providers to launch OMNY Health’s first suite of specialty databases. As the number of specialty treatment options expands, OMNY Health provides an ideal platform for delivering scalable data solutions to life sciences companies needing to understand the care delivered by the diverse mix of providers treating patients along their care journey. Data available on the platform provides the information needed to better understand the patient and provider landscape, design and identify eligible patients for trials, monitor the impact of launch of new therapies in the real-world setting, and evaluate safety and effectiveness of those therapies”, said Dr. Mitesh Rao, CEO at OMNY Health.

Investment in dermatology has experienced double-digit growth over the past several years and is expected to continue to grow, particularly for the conditions falling at the intersection of inflammatory and autoimmune skin disorders, such as alopecia areata, psoriasis, and atopic dermatitis. “We can now address the retrospective and prospective data and analytic needs of life sciences organizations working on treatments for some of the rarest dermatologic conditions, such as epidermolysis bullosa and generalized pustular psoriasis, to common conditions such as acne, and everything in between,” said Stacey Long, Chief Strategy Officer, who oversees OMNY Health’s product and data science teams.

“Advanced Dermatology and Cosmetic Surgery, the nation’s premier dermatology practice, values our partnership with OMNY. As we actively explore cutting edge therapeutics and leverage our robust data set to find ways to best serve our patients and the dermatology community, a collaboration with an advanced partner, like OMNY is crucial to our long-term success.” Allison W. Lynch, Chief Operating Officer, Clinical Research

“We are excited to partner with OMNY Health in looking at real world data. It’s an invaluable resource that creates improved patient outcomes, quality metrics, cost efficiencies, and tools for evaluating best practice opportunities. It also allows for prospective research to evaluate new ideas, therapies, and measurement tools that can assist in making better decisions for patients, physicians, payers, and the industry,” said Dr. Mark Jackson, Clinical Professor of Dermatology, University of Louisville and Director of Medical/Clinical Research, Forefront Dermatology.

Dr. Jackson will join Lawrence Rasouliyan, OMNY Health’s Head of Biostatistics and Data Science, on June 24, for a webinar discussion on the vital role of physicians in supporting real-world evidence generation in dermatology and the transformative opportunity for patients, providers, and life sciences organizations. Register at https://marketing-dev.omnyhealth.com/events-webinars/register-for-webinar-real-world-data-in-dermatology-why-it-matters/

About OMNY Health

OMNY Health connects patients, providers, and life sciences companies through data and insights to transform healthcare delivery, improve clinical outcomes, and address patient’s unmet needs. For more information, go to www.marketing-dev.omnyhealth.com or email: lifesciences@omnyhealth.com.

View full press release

Categories
Editorial

ISPOR Annual 2021 Sheds Light on Impact of COVID-19

The International Society of Pharmacoeconomics and Outcomes Research (ISPOR) annual conference was held May 14-17, 2021. Although the conference assumed a virtual format like last year due to the pandemic, it did not disappoint, as it was filled with lots of thought-provoking content and engaged interactive discussions. As expected, many of the sessions were focused on COVID-19 and its impact on health economics and outcomes research (HEOR). Here are a few highlights:

The opening plenary session, which consisted of a diverse group of panelists from around the globe, focused on the response of various health systems on the COVID-19 pandemic. Topics of discussion included the strengths and weaknesses of health systems exposed by the pandemic, their swift and cohesive responses, and the collaboration with the pharmaceutical industry to help bring vaccines to market in record time. Other particularly interesting sessions on the first day included access and inequalities of COVID-19 vaccines, quantitative bias analysis in measuring treatment effects in real-world data, and the effect of the pandemic on the real-world evidence generation.

The second- and third-day plenary sessions generated several lively discussions on methodological issues of HEOR assessments in the wake of the pandemic and the new types of collaborations in the HEOR space between traditional players (e.g., regulators, payers, and providers) and new players (e.g., digital health startups and technology companies). General sessions and issue panels focused on various topics, including access to combination therapy in oncology, the application of public health data to evaluate COVID-19 interventions, the increasing dependence on real-world evidence, handling missing data in analysis, real-world data transparency, and machine learning methods as they relate to HEOR topics.

Finally, the poster sessions provided much valuable information on a diverse range of HEOR topics. OMNY Health contributed 4 posters based on the analysis of real-world data from our platform on the topics of psoriasis, pressure ulcers, identifying COVID-19 patients from unstructured clinical notes, and the COVID-19 hospitalized patient experience.

These though-provoking sessions that primarily revolved around COVID-19 provided interesting perspectives into the impact of the pandemic on the acceleration of innovation in healthcare. As we re-surface from the pandemic and additional data and discussions about the reach of healthcare and utilization of data evolve, it will be interesting to see where the remainder of 2021 takes us.

To learn more about this story and how to partner with OMNY Health, please contact us.

Categories
Product

Accelerate the Pace of Life-Changing Innovation

Hidden deep in healthcare data lies powerful insights and clinical revelations. Knowledge, that when shared with healthcare visionaries, can spark actions that will accelerate the pace of life changing innovations.  Curating this wealth of knowledge requires precise data handling and a sharp focus on balancing two important factors:  Patient Privacy and Care Innovation.  

OMNY Health’s technology solutions deliver immediate value to Life Sciences researchers by delivering standardized patient, encounter, notes, and supply data from a diverse set of providers in a secure cloud platform. With off-the-shelf data, dashboards, reports, and analytics available in a variety of formats and combinations, time to insights and decisions accelerate, so your team can focus on improving access to effective treatments and transforming the lives of patients. OMNY works closely with integrated delivery networks, community hospital systems, and even specialty practices to harmonize their data, enable custom analytics and create a real-word data pipeline. 

These clinical insights are shared with Life Sciences companies for use in expediting Research & Development, driving new therapy launches and accelerating commercialization strategies. And while providers and pharmaceutical innovators benefit significantly from the standardization and flow of useful data, the ultimate winners are the patients.

Here’s an example:

Working with 2 health systems, we uncovered insights that directly informed treatment decisions for Myasthenia Gravis, or MG, patients and powered pre-launch research for a new innovative MG drug . What’s more, we provided real-world context to understand MG therapy burden and barriers to care.

Healthcare data holds the promise of clinical innovation. OMNY can connect you with the quality data you need to inform and transform actions that will make a real difference in patients’ lives. The future of healthcare is accessible today.

 To learn more about this story and how to partner with OMNY Health, please contact us.

Categories
News

OMNY Health Launches Platform to Accelerate Life-Changing Innovations through Data-Driven Insights

Connects data from hospitals, health systems, specialty medical groups with life sciences researchers 

ATLANTA, May 6, 2021 /PRNewswire/ — OMNY Health (OMNY Inc.) today announced commercial availability of the OMNY Health Platform™,  a healthcare data-sharing solution that accelerates innovation by connecting the healthcare ecosystem with opportunities to connect anonymized data with researchers from life sciences organizations. Platform clients can use this data to develop new therapies, enhance treatment availability, and measure effectiveness.

The use of anonymized real-world treatment data to support life sciences companies’ decision-making across healthcare is not new. It is, however, often done without the direct involvement of healthcare providers — the originators of the information. The OMNY Health Platform offers provider organizations of all sizes the ability to participate in data-sharing partnerships with life sciences organizations to support research activities in an efficient and compliant manner.

“As a healthcare executive focused on patient safety and quality, I was often frustrated with our inability to efficiently partner with life sciences companies to help address patients’ treatment challenges and understand unmet needs,” said Mitesh Rao MD, CEO and Founder of OMNY Health. “OMNY Health provides a trusted, compliant solution for patients and providers to build transparent and secure data-driven relationships at scale and with minimal effort.”

The OMNY Health Platform centers on de-identified, normalized electronic health record data, enhanced with tokens that support links across the data ecosystem, all while preserving patient anonymity.  A diverse set of hospitals, health systems, and specialty provider organizations have already agreed to join the network, representing care delivered in more than 39 states and more than 10 million patient lives.

The platform contains more than 100 pre-packaged searchable and downloadable data offerings, aligned to strategic therapeutic areas, drug classes, and procedure groups.  The direct-from-source data on the platform cover both inpatient and outpatient care and all payer types. OMNY can also provide custom data cuts and analyses for life sciences researchers.  Insights from these data can help better understand unmet patient needs, design more efficient clinical trials, and inform strategies to address challenges in access to care.

The number of organizations opting to participate on the data sharing platform is rapidly growing, as are the types of data being made available.

“We focused on creating a flexible, scalable architecture that supports the diverse set of data needed by life sciences organizations to meet multiple use cases across the value chain, and one that could easily integrate into their workflows,” said Sean O’Brien, co-founder and Chief Technology Officer at OMNY.  “Time and budget constraints can hinder life sciences companies from getting the information needed for faster, more-effective decision-making.  Our platform specifically addresses these challenges.”

Solution demonstrations and studies showcasing the diverse data available via the OMNY Health Platform are scheduled to be presented during a variety of events this summer, including ISPOR, DIA, and ICPE.

About OMNY Health OMNY Health connects patients, providers, and life sciences companies through data and insights to accelerate life-changing innovation.  Our easy-to-use, secure platform enables life sciences organizations to engage in collaborative data and research partnerships efficiently, compliantly, and at scale.

The team at OMNY Health imagines a future of patient-centered and evidence-based care. We’ll achieve that mission through a seamless workflow of analysis-to-insight-to-decision-making based on a connected ecosystem of healthcare data and collaboration across the healthcare ecosystem.   

For more information visit www.marketing-dev.omnyhealth.com or e-mail:lifesciences@omnyhealth.com.

View full press release

Categories
Product

How OMNY Health™ Is Supporting the Fight Against MG

OMNY Health™ worked closely with an innovative pharmaceutical company to support the launch of its Myasthenia Gravis (MG) drug by providing data from two of its health system partners.

Compiling in-depth information from more than 30 of our partnered medical facilities, we delivered a snapshot of the real-world healthcare encounters and treatment experience for over 1,700 patients via a secure, de-identified dataset. The OMNY Health Insights professional services team delivered dashboards characterizing the patient journey from initial interaction points to ultimate diagnosis and treatment, a solution that the pharma company’s claims data supplier could not provide. 

Of note, the insights collected enabled deeper insights into both inpatient and outpatient settings, as well as the broad spectrum of medical specialists delivering the care. Not surprising, variation in care was identified across physician specialty.

Armed with this data, our customer has optimized access to its product for patients in need. The insights our team provided allowed their global rare disease experts to better understand patient journeys without compromising privacy. 

Funds from this engagement have already routed back to the participating health systems for reinvestment, empowering them to hire more staff, improve frontline staff salaries, address budget challenges, and invest in new medical equipment. 

To learn more about this story and how to partner with OMNY Health, please contact us.

Categories
Product

OMNY Health’s Provider Leadership Council

OMNY Health™ is establishing a new Provider Leadership Council (PLC), comprised of executives from leading health systems and specialty networks interested in collaborating on opportunities to leverage real-world data and evidence to address the strategic imperatives facing the U.S. healthcare system.

The intent of the PLC is grounded in our vision for OMNY Health – to support providers in extracting value from their real-world data assets that frequently reside across disparate, fragmented information systems.  

We are inviting health system executives from large integrated networks and specialty medical groups to join us and help drive better evidence-based decisions across the industry. 

We believe this initiative will help health systems who are looking to address issues such as health equity, value-based care reimbursement, adapting to telemedicine/telehealth, as well as enabling patient-centered care initiatives.  Data and analytics will play a critical role in planning, executing, and evaluating the impact of approaches focused on tackling these challenges. 

The benefits of participating in the Provider Leadership Council include:

  • Early access to new features and functionality on the OMNY Health Platform
  • Opportunities to collaborate with OMNY Health on product strategy initiatives
  • Research initiatives to drive additional clinical research opportunities to provider institutions
  • Access to cutting edge technology such as AI and blockchain
  • Networking opportunities with opinion leaders and industry experts

OMNY Health plans to kick off the PLC in March 2021 (updated).  If you are a health system leader who would like to get involved or simply learn more, please contact us today.

Categories
Company Culture

Spotlight: Stacey Long, Chief Strategy Officer

OMNY Health™ talks to Stacey Long, our Chief Strategy Officer, about her experience at the company, her background in product management and consulting, and her interests in data analysis and engineering.

What leadership role were you holding before joining our team?

Prior to OMNY Health, I led the Real World Evidence team at IBM Watson Health where I oversaw the product management and consulting practices associated with IBM’s claims and EMR data products, analytical tools, and the associated consulting services organization.

What are the three words you would associate with OMNY Health and the team? 

Driven, creative, and fun!

What does your average day look like? 

As with many startups, I wear many hats on a typical day.  Primarily, I work with the leadership team to set the direction for the organization for our products, partnerships, and go-to-market approach.  I advise our Product Management and Engineering teams on developing and implementing our product roadmaps and help support the requirements building process.  In addition, I oversee our professional services team on client implementations building on my experience consulting and running consulting teams for the past 20 years.  I also spend a fair amount of time on research activities – staying up to date with industry trends and policy/regulatory changes related to our business activities so that we can ensure we are prepared to address industry pain points and remain compliant in our approaches.

What has been your favorite part of working here so far?  

I’ve really enjoyed digging into our existing data (I’m a data geek at heart) and working with the team to help shape the evolution of our platform and how we package the data and help our clients gain insights and value from the data, but most of all I’ve enjoyed getting to know the impressive OMNY Health team! Every day I am learning and innovating, which is very energizing!

What are your favorite pastimes outside of work? 

Taking long walks in nature with my family.  We live in upstate NY and are fortunate to have trails and beautiful waterfalls at our doorstep.

What is something that people would be surprised to learn about you?  

People are often surprised that I am relatively handy with machines.

My parents purchased a hundred year old farm home when I was a child and my father, who was an engineer, taught me at any early age how operate all types of equipment from an early age, not just the lawnmower, but things like chainsaws, log splitters, sanders, drills, etc.  My dad and I built our first computer together in the early 80’s, which got me hooked on programming and was influential in my career path.  I’ve just kicked off a project with my 10-year old daughter to build a treehouse in our backyard!

What future opportunities do you see for OMNY Health in the market?

With the rise of precision medicine, it’s an exciting time to be part of the data and analytics business, which shines in its ability to use advanced analytics to find the cohorts of patients or providers that would benefit most from greater access to targeted therapies.  We have a tremendous opportunity to bring together health systems, medical providers, manufacturers, and patients to improve care pathways and patient outcomes.

OMNY Health is unique in that we offer a secure, compliant platform to unite these stakeholders, as well as tools customized with patented technologies to deliver hard to extract insights from complex data streams such as physician notes, images, and labs.  The marketplace itself is easy to use and aims to provide either data or decision support tools to accelerate time to insights and improvements.

How do you see the company’s strategy evolving in these dynamic times? 

The availability of new streams of data from ‘omics, devices (e.g. IOT), and patient-reported outcomes provide new opportunities to deliver value back to health systems, providers, and patients to improve outcomes.  I foresee that we will continue to look at opportunities to bring these types of data together so that healthcare stakeholders can improve the quality of care that can be provided, but always focused on doing so in a secure and compliant environment.

Interested in learning more about OMNY Health? Set up a discussion today.

Categories
News

OMNY Health™ Debuts at Health 2.0 Launch!

OMNY Health took home the audience vote and the grand prize at Health 2.0

Eight new digital companies took the stage at Health 2.0’s Annual Conference in San Francisco on September 20, 2019 to give the first public demos of their products for the show’s annual “Launch!” event.

OMNY Health™, which aims to disrupt data sharing and give providers more control over the data they sell, took home the audience vote and the $5,000 grand prize. All eight companies boasted interesting ideas and impressive accomplishments so far, and we are honored to be in their company.

To read more, please visit mobihealthnews.com.

Categories
News

HealthTech Arkansas Names Six Startups to Cohort

HealthTech Arkansas named six startup companies, including OMNY Health™, for its second cohort on August 6th, 2019. HealthTech is an accelerator program for healthcare technology startup firms that will collaborate with nine healthcare providers in Arkansas.

The six companies were selected from hundreds of applicants across 18 different countries and are headquartered in innovation capitals like San Francisco, New York, Boston, San Diego, and Seattle. According to HealthTech leaders, the six companies already have 177 full-time employees and have raised over $90 million of external capital after forming the companies.

To read more, please visit talkbusiness.net.